FDA FY 1997 OTC drug funding is flat at $11.4 mil. in Clinton budget proposal.
This article was originally published in The Tan Sheet
FDA FY 1997 OTC DRUG PROGRAM FUNDING IS FLAT IN CLINTON BUDGET PROPOSAL at $11,406,000, compared with appropriations of $11,361,000 in fiscal 1996. Full-time equivalent slots for OTC drug evaluation are increased by only one, to 112, for 1997. The administration's budget proposal was presented to Congress on March 19.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC